BFM
IRON icon

Boothbay Fund Management’s Disc Medicine IRON Stock Holding History

Boothbay Fund Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$293K Buy
+4,000
New +$275K ﹤0.01% 1741
2024
Q2 		– Sell
-12,900
Closed -$803K – 1696
2024
Q1 		$803K Buy
+12,900
New +$836K 0.02% 826
2023
Q4 		– Sell
-5,600
Closed -$263K – 1814
2023
Q3 		$263K Buy
+5,600
New +$280K 0.01% 1308
2021
Q4 		– Sell
-2,670
Closed -$324K – 2031
2021
Q3 		$324K Buy
+2,670
New +$365K 0.01% 1293

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Boothbay Fund Management's IRON Position: Q2 2026 in Review

Boothbay Fund Management sold out of Disc Medicine (IRON) in Q2 2026, closing a stake of 21,378 shares — an estimated $1.47M sold.

Boothbay Fund Management first reported a position in IRON in Q1 2021 and held it in 11 quarters. The position peaked at $2.49M in Q4 2023. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Boothbay Fund Management reported no remaining Disc Medicine position as of Q2 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 21,378 Disc Medicine shares in Q2 2026, an estimated $1.47M.
  • Boothbay Fund Management first reported a position in Disc Medicine in Q1 2021 and held it in 11 quarters.
  • Boothbay Fund Management's Disc Medicine position peaked at $2.49M in Q4 2023.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.